<DOC>
	<DOCNO>NCT02852278</DOCNO>
	<brief_summary>The purpose study learn rate patient-reported disease progression patient motor neuron disease ( amyotrophic lateral sclerosis , progressive muscular atrophy , primary lateral sclerosis , hereditary spastic paraplegia ) outside clinical setting , patient-reported clinical characteristic influence rate progression . All patient enrol CReATe Connect , Rare Diseases Clinical Research Network ( RDCRN ) Contact Registry , invite via email participate study .</brief_summary>
	<brief_title>A Patient Centric Motor Neuron Disease Activities Daily Living Scale</brief_title>
	<detailed_description>The patient activity daily live amyotrophic lateral sclerosis survey ( PADL-ALS , Appendix B ) patient-centric revision standard revise ALS functional rating scale use clinical trial , ALSFRS-R . The PADL-ALS develop base patient interview , patient focus group . The ALSFRS-R make 12 category detail various activity daily live include six bulbar-respiratory function , three upper extremity function ( write , cut food , dress ) , three gross motor function ( walk , climb , turn bed ) . Each activity record close approximation list five choice , score 0-4 , total score range 48 ( normal function ) 0 ( function ) . The PADL-ALS include question ALSFRS-R , revision make question easy understand . In addition PADL-ALS contain question pain ; question emotional lability ; general non-denominational question faith . The survey compose two part , initial survey , monthly follow survey . The initial survey include PADL-ALS additional question symptom onset , date diagnosis , initial region involve , patient impression diagnosis , general demographic question ( age , gender , race , ethnicity , education ) , medication related diagnosis motor neuron disease . The survey data store Rare Diseases Clinical Research Network 's Data Management Coordinating Center ( DMCC ) University South Florida . Upon conclusion study period , data send Jeffrey Statland , MD , University Kansas Medical Center ( Study Chair ) Michael Benatar , MD , PhD , University Miami ( CReATe Consortium PI ) . All data collect sent database Genotypes Phenotypes ( dbGaP ) store indefinitely .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Muscular Atrophy</mesh_term>
	<mesh_term>Paraplegia</mesh_term>
	<mesh_term>Spastic Paraplegia , Hereditary</mesh_term>
	<mesh_term>Muscular Atrophy , Spinal</mesh_term>
	<criteria>Selfreported diagnosis motor neuron disease ( amyotrophic lateral sclerosis , amyotrophic lateral sclerosis frontotemporal dementia , primary lateral sclerosis , progressive muscular atrophy , hereditary spastic paraplegia ) Enrolled CReATe Connect , RDCRN Contact Registry Individuals age , race , ethnicity , location able participate Participants need able fill survey English â€¢ Inability provide inform consent complete survey</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>ALS</keyword>
	<keyword>motor neuron disease</keyword>
	<keyword>Progressive Muscular Atrophy</keyword>
	<keyword>Primary Lateral Sclerosis</keyword>
	<keyword>Hereditary Spastic Paraplegia</keyword>
</DOC>